Compare Stocks

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INKA KludeIn I Acquisition	$10.42 +2.7%	$10.45	$9.65 ▼ $14.84	$153.35M	0.01	53,931 shs	166,700 shs
NGAB Northern Genesis Acquisition Corp. II		$9.93	$9.55 ▼ $10.30	$513.88M	N/A	193,740 shs	179,400 shs
NGC Northern Genesis Acquisition Corp. III	$10.16 +0.1%	$10.15	$9.74 ▼ $10.20	$219.05M	0.01	99,227 shs	676,100 shs
PHIC Population Health Investment	$10.07 -0.1%	$10.06	$9.74 ▼ $10.08	$217.11M	-0.03	30,142 shs	1,000 shs

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INKA KludeIn I Acquisition	0.00%	0.00%	0.00%	0.00%	0.00%
NGAB Northern Genesis Acquisition Corp. II	0.00%	0.00%	0.00%	0.00%	0.00%
NGC Northern Genesis Acquisition Corp. III	0.00%	0.00%	0.00%	0.00%	0.00%
PHIC Population Health Investment	0.00%	0.00%	0.00%	0.00%	0.00%

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INKA KludeIn I Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NGAB Northern Genesis Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NGC Northern Genesis Acquisition Corp. III	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHIC Population Health Investment	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INKA KludeIn I Acquisition	N/A	N/A	N/A	N/A
NGAB Northern Genesis Acquisition Corp. II	N/A	N/A	N/A	N/A
NGC Northern Genesis Acquisition Corp. III	N/A	N/A	N/A	N/A
PHIC Population Health Investment	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INKA KludeIn I Acquisition	N/A	N/A	$0.35 per share	29.67	($0.67) per share	N/A
NGAB Northern Genesis Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A
NGC Northern Genesis Acquisition Corp. III	N/A	N/A	$0.11 per share	92.68	($0.61) per share	N/A
PHIC Population Health Investment	N/A	N/A	$0.27 per share	37.08	($0.34) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INKA KludeIn I Acquisition	-$410K	N/A	∞	N/A	N/A	-48.99%	3.60%	N/A
NGAB Northern Genesis Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NGC Northern Genesis Acquisition Corp. III	$2.36M	N/A	∞	N/A	N/A	-57.94%	3.40%	N/A
PHIC Population Health Investment	$5.86M	N/A	∞	N/A	N/A	-76.36%	3.98%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INKA KludeIn I Acquisition	N/A	N/A	N/A	N/A	N/A
NGAB Northern Genesis Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
NGC Northern Genesis Acquisition Corp. III	N/A	N/A	N/A	N/A	N/A
PHIC Population Health Investment	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INKA KludeIn I Acquisition	N/A	0.02	0.10
NGAB Northern Genesis Acquisition Corp. II	N/A	0.79	0.79
NGC Northern Genesis Acquisition Corp. III	N/A	0.12	0.12
PHIC Population Health Investment	N/A	0.12	0.12

Ownership

Institutional Ownership

Company	Institutional Ownership
INKA KludeIn I Acquisition	65.73%
NGAB Northern Genesis Acquisition Corp. II	51.89%
NGC Northern Genesis Acquisition Corp. III	72.80%
PHIC Population Health Investment	70.47%

Insider Ownership

Company	Insider Ownership
INKA KludeIn I Acquisition	7.02%
NGAB Northern Genesis Acquisition Corp. II	N/A
NGC Northern Genesis Acquisition Corp. III	N/A
PHIC Population Health Investment	3.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
INKA KludeIn I Acquisition	4	14.72 million	13.68 million	Not Optionable
NGAB Northern Genesis Acquisition Corp. II	N/A	51.75 million	N/A	Not Optionable
NGC Northern Genesis Acquisition Corp. III	147,000	21.56 million	N/A	Not Optionable
PHIC Population Health Investment	5	21.56 million	20.91 million	Not Optionable

NGAB, NGC, INKA, and PHIC Headlines

Source	Headline
	Population Health Investment Co Inc (PHIC) investing.com - March 30 at 9:26 PM
	Funding Equity in Health Workforce Development ssir.org - February 19 at 1:16 PM
	What Type Of Shareholders Own The Most Number of Population Health Investment Co., Inc. (NASDAQ:PHIC) Shares? finance.yahoo.com - February 17 at 5:23 AM
	Population Health Investment Co., Inc. Class A Ordinary Share (PHIC) Revenue EPS nasdaq.com - February 12 at 5:58 PM
	Population Health Investment Co., Inc. Class A Ordinary Share (PHIC) nasdaq.com - January 19 at 10:53 PM
	Population Health Investment EV to EBITDA ycharts.com - December 18 at 6:56 PM
	Population Health Investment Return on Assets ycharts.com - December 18 at 6:56 PM
	Population Health Investment Co., Inc. (PHIC) finance.yahoo.com - October 27 at 12:58 AM

Company Descriptions

KludeIn I Acquisition

NASDAQ:INKA

KludeIn I Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on completing a business combination with a software or technology-enabled business serving consumers or enterprises in the United States. The company was incorporated in 2020 and is based in Berkeley, California.

Northern Genesis Acquisition Corp. II

NYSE:NGAB

Northern Genesis Acquisition Corp. II focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Kansas City, Missouri.

Northern Genesis Acquisition Corp. III

NYSE:NGC

Northern Genesis Acquisition Corp. III does not have significant operations. It focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Kansas City, Missouri.

Population Health Investment

NASDAQ:PHIC

Population Health Investment Co., Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial